NCT06819982

Brief Summary

The aim of the AUDACE study is to evaluate the 'Bien chez Moi 2.0' programme, to assess how, for whom and why do assistive devices, integrated with occupational therapy support, enable older people to remain at home, and under what conditions? The study assesses the impact on areas such as the degree of autonomy, the extent to which life goals are taken into account, the feeling of security at home, the use of hospital emergency services and the postponement of definitive institutionalisation in a nursing home. The expected results of this study are to be able to robustly describe the impact of the 'Bien chez moi 2.0' programme in the areas listed above.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,900

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 11, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2025

Completed
Last Updated

February 11, 2025

Status Verified

January 1, 2025

Enrollment Period

1.5 years

First QC Date

January 28, 2025

Last Update Submit

February 5, 2025

Conditions

Keywords

Education, ContinuingHome Care ServicesMonitoring, AmbulatoryOccupational TherapyPersonal AutonomyPrimary Health Care / methodsProgram EvaluationSelf-Help Devices

Outcome Measures

Primary Outcomes (1)

  • COPM

    Endpoints will be calculated as the within-subject difference in measurement between baseline and six-month follow-up in Canadian Occupational Performance Measure (COPM), assessing daily occupations of importance that people are unable to perform. Scale description: Canadian Occupational Performance Measure Range 1-10 Higher score = Better outcome

    At enrolment and six months follow up.

Secondary Outcomes (7)

  • Short FES-I

    At enrolment and six months follow up.

  • Health-related QoL

    At enrolment and six months follow up.

  • Hospitalisation

    At enrolment and six months follow up.

  • Use of assistive devices

    At enrolment and six months follow up.

  • Sense of security

    At enrolment and six months follow up.

  • +2 more secondary outcomes

Study Arms (1)

BCM2.0

EXPERIMENTAL

The BCM2.0 programme provides occupational therapy sessions and assistive devices to support older people who want to age in place.

Other: BCM2.0

Interventions

BCM2.0OTHER

The BCM2.0 programme provides occupational therapy sessions and assistive devices to support older people who want to age in place.

BCM2.0

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • people aged 65 and over
  • living at home in the Walloon and Brussels regions
  • who are considered frail or at risk of frailty. The risk of frailty is defined as having at least one loss of intrinsic capacity measured by a trained occupational therapist using the ICOPE screening tool

You may not qualify if:

  • People benefiting from other AViQ autonomy programmes of this project are excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ergo2.0

Yvoir, B-5530, Belgium

RECRUITING

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 11, 2025

Study Start

March 4, 2024

Primary Completion

September 4, 2025

Study Completion

September 4, 2025

Last Updated

February 11, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

IPD will be shared for all collected data. Pseudonymised individual study data will undergo an anonymisation process with the help of an expert in data anonymity to ensure that no combination of data would allow re-identification of participants. The data will be publicly available on UCLouvain's public open data repository http://dataverse.uclouvain.be/.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
IPD will be shared after the complete study data has been collected and anonymised (expected data: january 2026). This data will remain available on dataverse.uclouvain.be with no end date. ICF and study protocol will be published in a scientific journal. This data will remain available on the journal website with no end date.

Locations